BIRC6

baculoviral IAP repeat containing 6, the group of MicroRNA protein coding host genes|Baculoviral IAP repeat containing|Ubiquitin conjugating enzymes E2

Basic information

Region (hg38): 2:32357023-32619571

Links

ENSG00000115760NCBI:57448OMIM:605638HGNC:13516Uniprot:Q9NR09AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BIRC6 gene.

  • not_specified (454 variants)
  • BIRC6-related_disorder (77 variants)
  • not_provided (47 variants)
  • Hereditary_breast_ovarian_cancer_syndrome (1 variants)
  • Autism_spectrum_disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BIRC6 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016252.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
34
clinvar
22
clinvar
56
missense
461
clinvar
13
clinvar
11
clinvar
485
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
Total 0 0 463 47 33
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BIRC6protein_codingprotein_codingENST00000421745 74261871
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.001.32e-241255580511256090.000203
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.2119642.41e+30.8160.00012231421
Missense in Polyphen6941097.40.632414419
Synonymous-1.879498791.080.00004529686
Loss of Function12.5142100.06660.00001082822

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001770.000177
Ashkenazi Jewish0.000.00
East Asian0.00005470.0000544
Finnish0.0001940.000185
European (Non-Finnish)0.0003380.000317
Middle Eastern0.00005470.0000544
South Asian0.00003320.0000327
Other0.0007080.000653

dbNSFP

Source: dbNSFP

Function
FUNCTION: Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification. {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}.;
Pathway
Apoptosis - multiple species - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);Apoptosis Modulation and Signaling (Consensus)

Recessive Scores

pRec
0.0958

Intolerance Scores

loftool
0.389
rvis_EVS
-4.33
rvis_percentile_EVS
0.11

Haploinsufficiency Scores

pHI
0.231
hipred
Y
hipred_score
0.648
ghis
0.645

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.892

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Birc6
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; embryo phenotype; immune system phenotype;

Gene ontology

Biological process
protein phosphorylation;ubiquitin-dependent protein catabolic process;apoptotic process;cell cycle;positive regulation of cell population proliferation;negative regulation of endopeptidase activity;protein ubiquitination;regulation of cytokinesis;regulation of cell population proliferation;negative regulation of apoptotic process;cell division;labyrinthine layer development;spongiotrophoblast layer development;negative regulation of extrinsic apoptotic signaling pathway
Cellular component
spindle pole;nucleus;endosome;trans-Golgi network;microtubule organizing center;membrane;midbody;Flemming body
Molecular function
ubiquitin-protein transferase activity;cysteine-type endopeptidase inhibitor activity;protein binding;ubiquitin conjugating enzyme activity